Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor

Cancer Research

Volumn 58, Issue 11, 1998, Pages 2477-2484

  Hongo, Atsushi ^b   Yumet, Gladys ^a   Resnicoff, Mariana ^a   Romano, Gaetano ^a   O'Connor, Rosemary ^c   Baserga, Renato ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMINO ACID; SOMATOMEDIN C RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CLONOGENESIS; COLONY FORMATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; MYRISTYLATION; NONHUMAN; PHOSPHORYLATION; PLASMID; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; MYRISTIC ACID; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PEPTIDE FRAGMENTS; RECEPTOR, IGF TYPE 1; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0032101640     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Stiles, C. D., Capone, G. T., Scher, C. D., Antoniades, N. H., Van Wyk, J. J., and Pledger, W. J. Dual control of cell growth by somatomedins and platelet derived growth factor. Proc. Natl. Acad. Sci. USA, 76: 1279-1283, 1979.
2. Liu, J-P., Buker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-1) and type 1 IGF receptor (Igf1r). Cell, 75: 59-72, 1993.
3. Baker, J., Liu, J-P., Robertson, E. J., and Efstratiadis, A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 75: 73-82, 1993.
4. Baserga, R. The insulin-like growth factor 1 receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
5. McCubrey, J. A., Stillman, L. S., Mayhew, M. W., Algate, P. A., Dellow, R. A., and Kaleko, M. Growth promoting effects of insulin-like growth factor 1 (IGF-1) on hematopoietic cells. Overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor dependent cells by ligand dependent mechanism. Blood, 78: 921-929, 1991.
6. Rodriguez-Tarduchy, G., Collins, M. K. L., Garcia, I., and Lopez-Rivas, A. Insulin-like growth factor I inhibits apoptosis in IL-3 dependent hemopoietic cells. J. Immunol., 149: 535-540, 1992.
7. Harrington, E. A., Bennett, M. R., Fanidi, A., and Evan, G. I. c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J., 13: 3286-3295, 1994.
8. Dunn, S. E., Hardman, R. A., Kari, F. W., and Barrett, C. J. Insulin-like growth factor 1 (IGF-I) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res., 57: 2687-2693, 1997.
9. Resnicoff, M., Abraham, D., Yutanaiboonchai, W., Rotman, H., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
10. Resnicoff, M., Burgaud, J-L., Rotman, H. L., Abraham, D., and Baserga, R. Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor I receptors. Cancer Res., 55: 3739-3741, 1995.
11. D'Ambrosio, C., Ferber, A., Resnicoff, M., and Baserga, R. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res., 56: 4013-4020, 1996.
12. Prager, D., Li, H. L., Asa, S., and Melmed, S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor receptor mutant. Proc. Natl. Acad. Sci. USA, 91: 2181-2185, 1994.
13. Resnicoff, M., Coppola, D., Sell, C., Rubin, R., Ferrone, S., and Baserga, R. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res., 54: 4848-4850, 1994.
14. Resnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R., and Rubin, R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor I (IGF-I) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res., 54: 2218-2222, 1994.
15. Shapiro, D. N., Jones, B. G., Shapiro, L. H., Dias, P., and Houghton, P. J. Antisense-mediated reduction in insulin-like growth factor 1 receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Invest., 94: 1235-1242, 1994.
16. Neuenschwander, S., Roberts, C. T., Jr., and LeRoith, D. Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor 1 receptor antisense ribonucleic acid. Endocrinology, 136: 4298-4303, 1995.
17. Lee, C. T., Wu, S., Gabrivolich, D., Chen, H., Nadaf-Rahrov, S., Ciernick, I. F., and Carbone, D. P. Antitumor effect of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res., 56: 3038-3041, 1996.
18. Pass, H. L., Mew, D. J. Y., Carbone, M., Matthews, W. A., Domington, J. S., Baserga, R., Walker, C. L., Resnicoff, M., and Steinberg, S. M. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor I receptor. Cancer Res., 56: 4044-4048, 1996.
19. Rininsland, F., Johnson, T. R., Chernicky, C. L., Schulze, E., Burfeind, B., Ilan, J., and Ilan, J. Suppression of insulin-like growth factor I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells. Proc. Natl. Acad. Sci. USA, 94: 5854-5859, 1997.
20. Long, L., Rubin, R., Baserga, R., and Brodt, P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor I receptor. Cancer Res., 55: 1006-1009, 1995.
21. Sell, C., Baserga, R., and Rubin, R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.
22. Wu, Y., Tewari, M., Cui, S., and Rubin, R. Activation of the insulin-like growth factor I receptor inhibits tumor necrosis factor-induced cell death. J. Cell. Physiol., 168: 499-509, 1996.
23. Hsing, A. Y., Kadomatsu, K., Bonham, N. J., and Danielpour, D. Regulation of apoptosis induced by transforming growth factor β1 in nontumorigenic and tumorigenic rat prostatic epithelial cell lines. Cancer Res., 56: 5146-5149, 1996.
24. Prisco, M., Hongo, A., Rizzo, M. G., Sacchi, A., and Baserga, R. The IGF-I receptor as a physiological relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol. Cell. Biol., 17: 1084-1092, 1997.
25. Kulik, G., Klippel, A., and Weber, M. J. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol., 17: 1595-1606, 1997.
26. Turner, B. C., Haffty, B. G., Narayanan, L., Yuan, J., Havre, P. A., Gumbs, A. A., Kaplan, L., Burgaud, J. L., Carter, D., Baserga, R., and Glazer, P. M. Insulin-like growth factor I receptor overexpression mediates cellular resistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res., 57: 3079-3083, 1997.
27. D'Ambrosio, C., Valentinis, B., Prisco, M., Reiss, K., Rubini, M., and Baserga, R. Protective effect of the IGF-I receptor on apoptosis induced by okadaic acid. Cancer Res., 57: 3264-3271, 1997.
28. O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G. I., Baserga, R., and Blättler, W. A. The IGF-I receptor domains for protection from apoptosis are distinct from those required for proliferation and transformation. Mol. Cell. Biol., 17: 427-435, 1997.
29. Surmacz, E., Sell, C., Swantek, J., Kato, H., Roberts, C. T., Jr., LeRoith, D., and Baserga, R. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor I receptor. Exp. Cell Res., 218: 370-380, 1995.
30. Hongo, A., D'Ambrosio, C., Miura, M., Morrione, A., and Baserga, R. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene, 12: 1231-1238, 1996.
31. Liu, Y., Lehar, S., Corvi, C., Payne, G., Chittenden, T., and O'Connor, R. Expression of the IGF-I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells. Cancer Res., 58: 570-576, 1998.
32. Ullrich, A., Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kahuria, S., Chen, E., Jakobs, S., Francke, U., Ramachandran, J., and Fujita-Yamaguchi, Y. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J., 5: 503-512, 1986.
33. Miura, M., Surmacz., E., Burgaud, J. L., and Baserga, R. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J. Biol. Chem., 270: 22639-22644, 1995.
34. Li, S., Resnicoff, M., and Baserga, R. Effects of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem., 271: 12254-12260, 1996.
35. Gritz, L., and Davies, J. Plasmid-encoded hygromycin B resistance: the sequence of hygromycin phosphotransferase and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene (Amst.), 25: 179-188, 1983.
36. Folkman, J., and Moscona, A. Role of cell shape in growth control. Nature (Lond.), 273: 345-349, 1978.
37. Abraham, D., Lange, A. M., Yutanaviboonchai, W., Trpis, M., Dickerson, J. W., Swenson, B., and Eberhard, M. L. Survival and development of larval Onchocerca volvulus in primate and rodent hosts. J. Parasitol., 79: 571-582, 1993.
38. Burgaud, J-L., Resnicoff, M., and Baserga, R. Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem. Biophys. Res. Commun., 214: 475-481, 1995.
39. Sun, X. J., Miralpeix, M., Myers, M., Glasheen, E. M., Backer, J. M., Kahn, C. R., and White, M. F. Expression and function of IRS-1 in insulin signal transmission. J. Biol. Chem., 267: 22662-22672, 1992.
40. Myers, M. J., Sun, X. J., Cheatham, B., Jachna, B. R., Glasheen, E. M., Backer, J. M., and White, M. F. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology, 132: 1421-1430, 1993.
41. Rose, D. W., Saltiel, A. R., Majumdar, M., Decker, S. J., and Olefsky, J. M. Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction. Proc. Natl. Acad. Sci. USA, 91: 797-801, 1994.
42. Yamauchi, K., and Pessin, J. E. Enhancement or inhibition of insulin signaling by insulin receptor substrate 1 is cell context dependent. Mol. Cell. Biol., 14: 4427-4434, 1994.
43. Waters, S. B., Yamauchi, K., and Pessin, J. E. Functional expression of insulin receptor substrate-1 is required for insulin-stimulated mitogenic signal. J. Biol. Chem., 268: 22231-22234, 1993.
44. Baserga, R., Hongo, A., Rubini, M., Prisco, M., and Valentinis, B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta, 1332: 105-126, 1997.
45. Pietrzkowski, Z., Lammers, R., Carpenter, G., Soderquist, A. M., Limardo, M., Phillips, P. D., Ullrich, A., and Baserga, R. Constitutive expression of IGF-1 and IGF-1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Differ., 3: 199-205, 1992.
46. 1 arrest in vitro. J. Cell. Physiol., 99: 48-54, 1979.
47. Rak, J., Mitsuhashi, Y., Erdos, V., Huang, S., Filmus, J., and Kerbel, R. Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression of mutant c-H-ras oncogene expression. J. Cell Biol., 131: 1587-1598, 1995.
48. Lebowitz, P. F., Sakamuro, D., and Prendergast, G. Farnesyl transferase inhibitors induce apoptosis of ras-transformed cells denied substratum attachment. Cancer Res., 57: 708-713, 1997.
49. Schlaepfer, D. D., Hanks, S. K., Hunter, T., and van der Geer, P. Integrin-mediated signal transduction linked to ras pathway by Grb2 binding to focal adhesion kinase. Nature (Lond.), 372: 786-791, 1994.
50. Ruoslahti, F., and Reed, J. C. Anchorage dependence, integrins and apoptosis. Cell, 77: 477-478, 1994.
51. FAK during c-Myc-induced apoptosis is suppressed by integrin signalling. Oncogene, 12: 2689-2696, 1994.
52. Day, M. L., Foster, R. G., Day, K. C., Zhao, X., Humphrey, P., Swanson, P., Postigo, A. A., Zhang, S. H., and Dean, D. C. Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J. Biol. Chem., 272: 8125-8128, 1997.
53. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H., and Downward, J. Matrix adhesion and ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/AAkt cellular survival pathway. EMBO J., 16: 2783-2793, 1997.
54. Marshall, C. J. Raf gets it together. Nature (Lond.), 383: 127-128, 1996.
55. Klippel, A., Reinhard, C., Kavanaugh, W. M., Apell, G., Escobedo, M., and Williams, L. T. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol. Cell. Biol., 16: 4117-4127, 1996.
56. Marais, R., Light, Y., Paterson, H. F., and Marshall, C. J. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J., 14: 3136-3145, 1996.
57. Parrizas, M., Saltiel, A. R., and LeRoith, D. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem., 272: 154-161, 1997.